- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03002207
Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation
October 20, 2021 updated by: Zhanghao
A Prospective, Comparative Study to Evaluate Effectiveness of Repairing the Defect of Intervertebral Disc With Autologous BMSC and Gelatin Sponge After Microendoscopic Discectomy for Lumbar Disc Herniation
In this prospective study the investigators seek to evaluate clinical outcomes after repairing the defect of intervertebral disc with autologous BMSC/gelatin sponge during microendoscopic discectomy for participants of lumbar disc herniation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not.
In the first group,the defect of intervertebral disc is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge and sutured.
In the second group, the defect of intervertebral disc is repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge but not sutured after discectomy.
In the third group, the defect of intervertebral disc is sutured but not repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
In the four group, the defect of intervertebral disc is neither sutured nor repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Baoshan Xu
- Phone Number: 86-13502028198
- Email: xubaoshan99@126.com
Study Contact Backup
- Name: Yue Liu
- Phone Number: 86-13652006399
- Email: yourliuyue@126.com
Study Locations
-
-
-
Tianjin, China, 300211
- Recruiting
- Tianjin Hospital
-
Contact:
- Baoshan Xu
- Phone Number: 86-13502028198
- Email: xubaoshan99@126.com
-
Contact:
- Yue Liu
- Phone Number: 86-13652006399
- Email: yourliuyue@126.com
-
Sub-Investigator:
- Kaihui Zhang
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants with signs and symptoms of lumbar disc herniation requiring surgical treatment after conservative management;
- Radiological data on CT/MRI obtained within a period prior to enrollment;
- Participants give written informed consent before enrollment.
Exclusion Criteria:
- If participants had an incomplete medical record;
- Participants had spine tumor, spine infection, previous underwent lumbar surgery, or revision surgery.
- Participants are taking uninterruptible anticoagulation therapy.
- Dementia and/or inability to give informed consent.
- MRI contraindication (e.g. cerebral aneurysm clips, cochlear implants, pacemaker, implanted biostimulators);
- Pregnancy;
- Participation in other clinical trial within the last 30 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: The defect is repaired and sutured
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not.
In the first group,the defect of intervertebral disc is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge and sutured.
|
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and the defect of intervertebral disc is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and the defect is sutured after discectomy.
|
Experimental: The defect is repaired but not sutured
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not.
In the second group, the defect of intervertebral disc is repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge but not sutured after discectomy.
|
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and the defect of intervertebral disc is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
|
Experimental: The defect is sutured but not repaired
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not.
In the third group, the defect of intervertebral disc is sutured but not repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
|
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and the defect is sutured after discectomy.
|
No Intervention: The defect is neither sutured nor repaired
Participants with lumbar disc herniation diseases are treated by Microendoscopic discectomy, and they are divided into four groups depend on whether the defect is repaired with Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge or not and whether the defect is sutured or not.
In the four group, the defect of intervertebral disc is neither sutured nor repaired with autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge after discectomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline in Oswestry Disability Index(ODI)
Time Frame: Baseline, post-op 3 months, 6 months,12 months
|
The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel.Each topic category is followed by 6 statements describing different potential scenarios in the patient's life relating to the topic.
The patient then checks the statement which most closely resembles their situation.
Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability.
The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100).
Zero is equated with no disability and 100 is the maximum disability possible.
|
Baseline, post-op 3 months, 6 months,12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline in Visual Analogue Scale(VAS)
Time Frame: Baseline, post-op 3 months, 6 months,12 months
|
Self reported pain using a 10-point visual analogue scale (0=no pain;10=pain as bad as can be)
|
Baseline, post-op 3 months, 6 months,12 months
|
Changes from baseline in The Short Form (36) Health Survey(SF-36)
Time Frame: Baseline, post-op 3 months, 6 months,12 months
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
|
Baseline, post-op 3 months, 6 months,12 months
|
Change from Baseline in Magnetic Resonance Classification of Lumbar Intervertebral Disc Degeneration(Pfirrmann classification)
Time Frame: Baseline, post-op 12 months
|
The Pfirrmann grading system assesses degenerated intervertebral discs by MRI for the asymmetry in disc structure, distinction of the nucleus and the annulus, signal intensity of intervertebral discs and height of intervertebral discs and assigns grade I to V for disc degeneration。
|
Baseline, post-op 12 months
|
Change from Baseline in The Height of Disc on MRI Scans
Time Frame: Baseline, post-op 12 months
|
Using imaging software, physicians will measure disc height at the treatment discs on the midline T1 sagittal view
|
Baseline, post-op 12 months
|
Change from Baseline in The Size of Disc Protrusion
Time Frame: Baseline, post-op 12 months
|
We will measure the anteroposterior (AP) size of the disc protrusions that required treatment
|
Baseline, post-op 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Medical Records
Time Frame: 1 months after hospital discharge
|
The Medical Records including operative time、blood loss and hospital stay
|
1 months after hospital discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Xinlong Ma, Tianjin Hospital Of Tianjin
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005 Jul;87(7):1430-7. doi: 10.2106/JBJS.D.02215.
- Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015 Jan;33(1):146-56. doi: 10.1002/stem.1845.
- Sakai D, Andersson GB. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions. Nat Rev Rheumatol. 2015 Apr;11(4):243-56. doi: 10.1038/nrrheum.2015.13. Epub 2015 Feb 24.
- Yuan Q, Du L, Xu H, Zhang K, Li Q, Zhang H, Liu Y, Ma X, Xu B. Autologous Mesenchymal Stromal Cells Combined with Gelatin Sponge for Repair Intervertebral Disc Defect after Discectomy: A Preclinical Study in a Goat Model. Front Biosci (Landmark Ed). 2022 Apr 19;27(4):131. doi: 10.31083/j.fbl2704131.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2016
Primary Completion (Anticipated)
November 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
December 10, 2016
First Submitted That Met QC Criteria
December 20, 2016
First Posted (Estimate)
December 23, 2016
Study Record Updates
Last Update Posted (Actual)
October 21, 2021
Last Update Submitted That Met QC Criteria
October 20, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016(001)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Disc Herniation
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingLumbar Disc Herniation | Lumbar Disc DegenerationChina
-
Shin Kong Wu Ho-Su Memorial HospitalTerminatedLumbar Disc Herniation | Lumbar Traction | Spinal Manipulation | Lumbar SurgeryTaiwan
-
Intrinsic TherapeuticsActive, not recruitingLumbar Disc Herniation | Annular Disc Tear | Annular Tear of Lumbar DiscBelgium, Germany
-
Allina Health SystemTwin Cities Spine CenterRecruitingLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Disc DiseaseUnited States
-
Holger JoswigCompletedLumbar Disc Herniation | Cervical Disc HerniationSwitzerland
-
Jaseng Medical FoundationRecruitingLumbar Disc HerniationKorea, Republic of
-
Firat UniversityRecruiting
-
Eastern Mediterranean UniversityRecruiting
-
Ramathibodi HospitalNot yet recruitingLumbar Disc Herniation
-
Zhou XingchenActive, not recruitingLumbar Disc HerniationChina
Clinical Trials on Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge
-
MD Stem CellsEnrolling by invitationAlzheimer Disease | Traumatic Brain Injury | Autism Spectrum Disorder | Lewy Body Disease | Vascular Dementia | Autism | Dementia, Mixed | Alzheimer Dementia | Dementia, Multi-Infarct | Cadasil | Parkinson-Dementia Syndrome | Chronic Traumatic Encephalopathy | Autistic Behavior | Lewy Body Dementia With Behavioral... and other conditionsUnited States, United Arab Emirates
-
Yamaguchi University HospitalUnknown
-
Manipal Acunova Ltd.Ministry of Science and Technology, IndiaCompleted
-
National Institute of Allergy and Infectious Diseases...Terminated
-
Federal University of BahiaOswaldo Cruz Foundation; Hospital Universitário Professor Edgard SantosUnknownSickle Cell Disease | Avascular Necrosis of Bone
-
Miltenyi Biotec B.V. & Co. KGGerman Federal Ministry of Education and ResearchTerminatedMyocardial Ischemia | Coronary Artery DiseaseGermany
-
Michael SekelaCompletedChronic Ischemic Heart DiseaseUnited States
-
University of Sao PauloCompletedAge Related Macular Degeneration and StargartdBrazil
-
Cairo UniversityUnknownDegenerative Arthritis | Chondral Defects | Osteochondral DefectsEgypt
-
Cairo UniversityUnknownBone Resorption | Alveolar Bone Loss | Alveolar Bone Resorption | Bone Graft Failure